Skip to main content

Ananda Goldrath to Lead Allen Institute for Immunology

Dr. Ananda Goldrath will join as the Executive Vice President of the Allen Institute for Immunology in fall of 2023.


1 min read

The Allen Institute today announced the hiring of Dr. Ananda Goldrath as Executive Vice President of the Allen Institute for Immunology. Dr. Goldrath comes to the Institute from the University of California, San Diego where she most recently served as Tata Chancellor’s Professor of Molecular Biology.

“Emerging research, technology, and tools – some pioneered at the Allen Institute – are opening new windows into the immune system,” said President & CEO Rui Costa. “With Dr. Goldrath’s expertise and leadership, we have an opportunity to catalyze discoveries that move the field of immunology forward and provide a foundation for understanding human health and disease.”

Dr. Goldrath is a leading expert in immune memory. This is the immune system’s ability to “remember” an infection by a particular virus or bacteria, and then mount a robust immune response when it encounters that same pathogen in the future to prevent reinfection. Immune memory is the basis by which vaccines provide protection from dangerous infections.

“I am thrilled to be joining the Allen Institute for Immunology’s phenomenal team,” said Goldrath. “The opportunity to build on the Institute’s unprecedented deep immune profiling will reveal underlying biology and molecular pathways of cellular interactions regulating immune responses throughout the body, enabling novel insights for the field of Immunology and for improving human health.”

Dr. Goldrath succeeds Tom Bumol, a pharma industry veteran who helped launch the Allen Institute for Immunology in 2018. Goldrath officially joins the Allen Institute in the fall.

About the Allen Institute for Immunology

The Allen Institute for Immunology  is a division of the Allen Institute, an independent, 501(c)(3) nonprofit medical research organization, and is dedicated to understanding the dynamic balancing act of the human immune system in health and disease. The Allen Institute for Immunology will advance our fundamental understanding of the human immune system and will identify new therapeutic avenues for disease by employing a multi-disciplinary team approach in collaboration with leading research organizations, generating novel insights about cellular and molecular drivers of immune health and immune-related diseases. The Allen Institute for Immunology will be launched in 2018 with a contribution from founder and philanthropist, the late Paul G. Allen. The data and tools generated by the Allen Institute for Immunology will be publicly available online.

Science Programs at Allen Institute